The CaixaImpulse Innovation programme, whose call for submissions for 2024 has just been concluded, aims to accelerate the market release of the outcomes of 29 biomedical projects from Spain and Portugal.
To achieve this goal, each initiative receives up to €500,000 in funding, as well as training and expert support. Our partner in the Chemistry and Materials department, Sofia Pettersson, is one of the specialists that has contributed on this edition.
Intellectual property strategies in the field of therapeutics
The European Patent Attorney recently delivered a presentation on intellectual property strategy for the therapeutic field. Starting with basic topics like what a patent is and how to obtain one, she completed an overview of the value of processing and obtaining legal ownership over innovations.
As a result, her discussion will help those selected in the CaixaImpulse Innovation programme to have a global perspective in order to protect their inventions properly,which will contribute significantly to raising funds to continue developing their research. It will also facilitate the establishment of alliances and prevent them from infringing on the intellectual property of others, among other benefits.
3,4 million euros for 29 biomedical projects
The “la Caixa” Foundation will spend 3.4 million euros overall this edition to support the chosen initiatives and accelerate their developments to reach patients.
Among this year’s selected projects are those that aim to validate a tool to help predict the genetic risk of myocardial infarction and sudden death in young people; the development of a non-invasive method to detect endometrial cancer using urine samples, among many others.
